Atlassian earnings analysis: questions answered and next catalysts

Atlassian (TEAM) reported FY2027 Q1 earnings on Nov 5, 2026, beating EPS and revenue estimates. Despite the beat, shares fell 15.09% to $155.64. Cloud growth was 30.5%, but guidance was lowered. Analysts have mixed views on the stock's future. Next catalysts include Q2 earnings and cloud growth trends.

Original reporting
Published Nov 6, 2026, 5:57 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 6:07 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$TEAM
Bearish
medium confidence
Mentioned
$TEAM
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$TEAMBearishMed
01

Why it matters

The actionable trading focus is the gap between Q1 delivery and FY2027 guidance, plus the guided deceleration in cloud growth and subscription ARR, which can drive estimate revisions ahead of FY2027 Q2.

02

Market read

Guidance deceleration after an earnings beat is the core catalyst, with investors likely to reassess FY2027 growth durability and AI monetization timing.

03

What to watch

Data Center hybrid deployments reportedly lifted Data Center revenue and held back cloud, which could mean cloud growth optics are temporarily distorted rather than structurally deteriorating.

Relevance 7/10Novelty 5/10Timing: into the next earnings window, with FY2027 Q2 earnings tentatively Feb 4, 2027

Background

The piece frames Atlassian’s FY2027 Q1 results as a beat on EPS and revenue, followed by a sharp drop, then maps what bulls and bears see as the key remaining uncertainties.

Company-level read

Ticker impact

$TEAMBearishMedium confidence
Context

Atlassian (TEAM) beat FY2027 Q1 EPS and revenue but shares fell, with the article highlighting decelerating FY2027 guidance and cloud reacceleration concerns.

Expected impact

Likely continued pressure as investors reprice FY2027 growth deceleration and AI monetization timing risk ahead of the next quarter.

Evidence & confidence

The article ties the drop to guidance that slows versus Q1 results (FY2027 revenue growth ~13.75% vs ~24% delivered; subscription ARR ~18.5% vs ~23% reported) and flags cloud growth guidance below Q1.

Market effects

Reinforces a broader enterprise software narrative that cloud reacceleration and AI monetization timing can drive valuation resets even after EPS/revenue beats.

Limited direct regional spillover; primarily affects US-listed enterprise software sentiment.

Moderate read-through for global SaaS investors focused on cloud growth durability and AI investment efficiency.

Counterpoint

The beat metrics and retention strength (cloud net revenue retention above 120%) suggest underlying demand remains intact; the selloff may be overreacting to conservative pass-through of upside.

Key entities

  • Atlassian

    Subject of the article; FY2027 Q1 results beat but shares fell on guidance deceleration and cloud reacceleration concerns.

  • KeyBanc

    Cited as noting the EPS beat streak and smaller revenue beat versus prior quarters.

  • Guggenheim

    Cited on seat growth from competitive displacements and cloud/ARR dynamics.

  • Canaccord

    Cited on the hybrid transition and expectations for cloud and Data Center trends.

  • Truist

    Cited for cutting its AI-related target to $200 from $250, citing cloud sustainability and AI investment costs.

Related articles

$TEAMMedAI 8/10

Atlassian Sinks 12% as Slower Growth Outlook Overshadows Beat: “Enterprise AI Has Hit an Inflection Point”

Atlassian (TEAM) shares fell 12% after guiding to 13.75% revenue growth for fiscal 2027, down from 24% last quarter. The slowdown is partly due to the planned wind-down of its Data Center software. The company beat earnings estimates for Q1, with revenue up 24% to $1.77 billion and adjusted EPS of $1.65. Analysts note the stock's P/E ratio is now 28x, below its 5-year average of 81x. Competitors monday.com (MNDY) and Salesforce (CRM) will report soon.